Evidence of an important role for SV40 in mesothelioma

Thoracic Surgery Clinics

Volumn 14, Issue 4 SPEC. ISS., 2004, Pages 489-495

  Pass, Harvey I ^a,c   Bocchetta, Maurizio ^b   Carbone, Michele ^b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOYOLA UNIVERSITY HEALTH SYSTEM   (United States)

^c HARPER UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASBESTOS; CARCINOGEN; CROCIDOLITE; DOUBLE STRANDED DNA; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; PHOSPHATASE; POLIOMYELITIS VACCINE; PROTEIN; PROTEIN P107; PROTEIN P130; PROTEIN P300; PROTEIN P400; PROTEIN P53; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

BONE TUMOR; BRAIN TUMOR; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER RISK; CARCINOGENESIS; DNA VIRUS; DRUG CONTAMINATION; HUMAN; IMMUNIZATION; LYMPHOMA; MESOTHELIOMA; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SIMIAN VIRUS 40; TUMOR BIOPSY; TUMOR SUPPRESSOR GENE;

EID: 4744362667     PISSN: 15474127     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thorsurg.2004.06.003     Document Type: Review

References (43)

1. M. Carbone, R.A. Kratzke, and J.R. Testa The pathogenesis of mesothelioma Semin Oncol 29 1 2002 2 17
2. M. Bocchetta, R.I. Di, A. Powers, R. Fresco, A. Tosolini, and J.R. Testa Human mesothelial cells are unusually susceptible to simian virus 40-mediated transformation and asbestos cocarcinogenicity Proc Natl Acad Sci U S A 97 18 2000 10214 10219
3. J. Yu, A. Boyapati, and K. Rundell Critical role for SV40 small-t antigen in human cell transformation Virology 290 2 2001 192 198
4. P. Cacciotti, R. Libener, P. Betta, F. Martini, C. Porta, and A. Procopio SV40 replication in human mesothelial cells induces HGF/Met receptor activation: a model for viral-related carcinogenesis of human malignant mesothelioma Proc Natl Acad Sci U S A 98 21 2001 12032 12037
5. R. Foddis, A. De Rienzo, D. Broccoli, M. Bocchetta, E. Stekala, and P. Rizzo SV40 infection induces telomerase activity in human mesothelial cells Oncogene 21 9 2002 1434 1442
6. W.C. Hahn, S.K. Dessain, M.W. Brooks, J.E. King, B. Elenbaas, and D.M. Sabatini Enumeration of the simian virus 40 early region elements necessary for human cell transformation Mol Cell Biol 22 7 2002 2111 2123
7. A.F. Gazdar, J.S. Butel, and M. Carbone SV40 and human tumours: myth, association or causality? Nat Rev Cancer 2 12 2002 957 964
8. B. Jasani, C.J. Jones, C. Radu, D. Wynford-Thomas, H. Navabi, and M. Mason Simian virus 40 detection in human mesothelioma: reliability and significance of the available molecular evidence Front Biosci 6 2001 E12 E22
9. M. Carbone, H.I. Pass, P. Rizzo, M. Marinetti, M. Di Muzio, and D.J.Y. Mew Simian virus 40-like DNA sequences in human pleural mesothelioma Oncogene 9 1994 1781 1790
10. M. Carbone, P. Rizzo, and H.I. Pass Simian virus 40, poliovaccines and human tumors: a review of recent developments Oncogene 15 1997 1877 1888
11. M. Ramael, and J. Nagels SV40-like DNA sequences in pleural mesothelioma, bronchopulmonary carcinoma and non-malignant pulmonary disease [comment] J Pathol 189 4 1999 628 629
12. N. Shivapurkar, T. Wiethege, I. Wistuba, E. Salomon, S. Milchgrub, and K.M. Muller Presence of simian virus 40 sequences in malignant mesotheliomas and mesothelial cell proliferations J Cell Biochem 76 2 1999 181 188
13. J.R. Testa, M. Carbone, A. Hirvonen, K. Khalili, B. Krynska, and K. Linnainmaa A multi-institutional study confirms the presence and expression of simian virus 40 in human malignant mesotheliomas Cancer Res 58 20 1998 4505 4509
14. A. Hirvonen, K. Mattson, A. Karjalainen, T. Ollikainen, L. Tammilehto, and T. Hovi SV40-like sequences not detectable in Finnish mesotheliomas not exposed to SV40-contaminated poliovaccines Mol Carcinog 26 1999 93 99
15. S. Emri, T. Kocagoz, A. Olut, Y. Gungen, L. Mutti, and Y.I. Baris Simian virus 40 is not a cofactor in the pathogenesis of environmentally induced malignant pleural mesothelioma in Turkey [see comments] Anticancer Res 20 2A 2000 891 894
16. A. De Rienzo, M. Tor, D.H. Sterman, F. Aksoy, S.M. Albelda, and J.R. Testa Detection of SV40 DNA sequences in malignant mesothelioma specimens from the United States, but not from Turkey J Cell Biochem 84 3 2002 455 459
17. A. Leithner, A. Weinhaeusel, R. Windhager, R. Schlegl, P. Waldner, and S. Lang Absence of SV40 in Austrian tumors correlates with low incidence of mesotheliomas Cancer Biol Ther 1 4 2002 375 379
18. G.J. Gordon, C.J. Chen, M.T. Jaklitsch, W.G. Richards, D.J. Sugarbaker, and R. Bueno Detection and quantification of SV40 large T-antigen DNA in mesothelioma tissues and cell lines Oncol Rep 9 3 2002 631 634
19. M.D. Innis Oncogenesis and poliomyelitis vaccine Nature 219 157 1968 972 973
20. O.P. Heinonen, S. Shapiro, R.R. Monson, S.C. Hartz, L. Rosenberg, and D. Slone Immunization during pregnancy against poliomyelitis and influenza in relation to childhood malignancy Int J Epidemiol 2 3 1973 229 235
21. J. Fraumeni, F. Ederer, and R.W. Miller An evaluation of the carcinogenicity of SV40 in man JAMA 185 1963 713 718
22. H.D. Strickler, P.S. Rosenberg, S.S. Devesa, J. Hertel, J.F. Fraumeni Jr, and J.J. Goedert Contamination of poliovirus vaccines with simian virus 40 (1955-1963) and subsequent cancer rates JAMA 279 4 1998 292 295
23. C. Carroll-Pankhurst, E.A. Engels, H.D. Strickler, J.J. Goedert, J. Wagner, and E.A. Mortimer Jr. Thirty-five year mortality following receipt of SV40 contaminated polio vaccines during the neonatal period Br J Cancer 85 9 2001 1295 1297
24. S.G. Fisher, L. Weber, and M. Carbone Cancer risk associated with simian virus 40 contaminated poliovaccine Anticancer Research 19 1999 2173 2180
25. E. Geissler SV40 and human brain tumors Prog Med Virol 37 1990 211 222
26. J.S. Butel, and J.A. Lednicky Cell and molecular biology of simian virus 40: implications for human infections and disease J Natl Cancer Inst 91 2 1999 119 134
27. K. Stratton, D.A. Almario, and M. McCormick IOM report: immunization safety review. Sv40 contamination of poliovaccine and cancer 2002 National Academy of Sciences Bethesda, MD
28. D. Ewald, M. Li, S. Efrat, G. Auer, R.J. Wall, and P.A. Furth Time-sensitive reversal of hyperplasia in transgenic mice expressing SV40 T antigen Science 273 5280 1996 1384 1386
29. Y.J. Tzeng, C. Zimmermann, E. Guhl, B. Berg, M.L. Avantaggiati, and A. Graessmann SV40 T/t-antigen induces premature mammary gland involution by apoptosis and selects for p53 missense mutation in mammary tumors Oncogene 16 16 1998 2103 2114
30. H. Salewski, T.A. Bayer, U. Eidhoff, U. Preuss, S. Weggen, and K.H. Scheidtmann Increased oncogenicity of subclones of SV40 large T-induced neuroectodermal tumor cell lines after loss of large T expression and concomitant mutation in p53 Cancer Res 59 8 1999 1980 1986
31. K. Moorwood, T.N. Price, and L.V. Mayne Mutation of p53 is not a prerequisite for immortalization of human fibroblasts by SV40 T antigen Exp Cell Res 223 2 1996 308 313
32. F. Jensen, H. Koprowski, J.S. Pagano, J. Ponten, and R.G. Ravdin Autologous and homologous implantation of human cells transformed in vitro by SV40 J Natl Cancer Inst 32 1964 917 925
33. I. Waheed, Z.S. Guo, G.A. Chen, T.S. Weiser, D.M. Nguyen, and D.S. Schrump Antisense to SV40 early gene region induces growth arrest and apoptosis in T-antigen-positive human pleural mesothelioma cells Cancer Res 59 24 1999 6068 6073
34. J.S. Butel Viral carcinogenesis: revelation of molecular mechanisms and etiology of human disease Carcinogenesis 21 3 2000 405 426
35. M. Carbone, P. Rizzo, P.M. Grimley, A. Procopio, D.J. Mew, and V. Shridhar Simian virus-40 large-T antigen binds p53 in human mesotheliomas [see comments] Nat Med 3 8 1997 908 912
36. A. De Luca, A. Baldi, V. Esposito, C.M. Howard, L. Bagella, and P. Rizzo The retinoblastoma gene family pRb/p105, p107, pRb2/p130 and simian virus-40 large T-antigen in human mesotheliomas [see comments] Nat Med 3 8 1997 913 916
37. S. Toyooka, H.I. Pass, N. Shivapurkar, Y. Fukuyama, R. Maruyama, and K.O. Toyooka Aberrant methylation and simian virus 40 tag sequences in malignant mesothelioma Cancer Res 61 15 2001 5727 5730
38. S. Toyooka, M. Carbone, K.O. Toyooka, M. Bocchetta, N. Shivapurkar, and J.D. Minna Progressive aberrant methylation of the RASSF1A gene in simian virus 40 infected human mesothelial cells Oncogene 21 27 2002 4340 4344
39. M. Bocchetta, L. Miele, H.I. Pass, and M. Carbone Notch-1 induction, a novel activity of SV40 required for growth of SV40-transformed human mesothelial cells Oncogene 22 1 2003 81 89
40. H.I. Pass, D.J. Mew, M. Carbone, J.S. Donington, R. Baserga, and S.M. Steinberg The effect of an antisense expression plasmid to the IGF-1 receptor on hamster mesothelioma proliferation Dev Biol Stand 94 1998 321 328
41. R. Robledo, and B. Mossman Cellular and molecular mechanisms of asbestos-induced fibrosis J Cell Physiol 180 2 1999 158 166
42. G. Klein, A. Powers, and C. Croce Association of SV40 with human tumors Oncogene 21 8 2002 1141 1149
43. M. Wong, J.S. Pagano, J.T. Schiller, S.S. Tevethia, N. Raab-Traub, and J. Gruber New associations of human papillomavirus, simian virus 40, and Epstein-Barr virus with human cancer J Natl Cancer Inst 94 24 2002 1832 1836